Forum Financial Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,971
Closed -$1.72M 926
2025
Q4
$1.72M Buy
2,971
+624
+27% +$353K 0.02% 155
2025
Q3
$1.14M Buy
2,347
+27
+1% +$12.6K 0.02% 216
2025
Q2
$941K Sell
2,320
-878
-27% -$367K 0.01% 228
2025
Q1
$1.59M Buy
3,198
+6
+0.2% +$3.25K 0.03% 144
2024
Q4
$1.66M Buy
3,192
+991
+45% +$545K 0.03% 139
2024
Q3
$1.36M Sell
2,201
-37
-2% -$21.9K 0.02% 146
2024
Q2
$1.24M Buy
2,238
+45
+2% +$25.8K 0.02% 150
2024
Q1
$1.27M Hold
2,193
0.02% 163
2023
Q4
$1.16M Sell
2,193
-3
-0.1% -$1.45K 0.02% 148
2023
Q3
$1.11M Buy
2,196
+3
+0.1% +$1.6K 0.02% 144
2023
Q2
$1.14M Buy
2,193
+7
+0.3% +$3.78K 0.03% 142
2023
Q1
$1.26M Sell
2,186
-33
-1% -$18.6K 0.04% 119
2022
Q4
$1.22M Sell
2,219
-34
-2% -$18K 0.04% 111
2022
Q3
$1.14M Buy
2,253
+5
+0.2% +$2.8K 0.06% 98
2022
Q2
$1.22M Buy
2,248
+3
+0.1% +$1.65K 0.06% 105
2022
Q1
$1.33M Sell
2,245
-109
-5% -$62.6K 0.06% 94
2021
Q4
$1.57M Buy
+2,354
New +$1.47M 0.08% 78

Other funds holding TMO

Forum Financial Management's TMO Position: Q1 2026 in Review

Forum Financial Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 2,971 shares — an estimated $1.72M sold.

Forum Financial Management first reported a position in TMO in Q4 2021 and held it in 17 quarters. The position peaked at $1.72M in Q4 2025. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Forum Financial Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Forum Financial Management sold 2,971 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.72M.
  • Forum Financial Management first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 17 quarters.
  • Forum Financial Management's Thermo Fisher Scientific position peaked at $1.72M in Q4 2025.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Forum Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.